MediWound (MDWD) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. WDAY
2. AAPL
3. JNJ
4. AMAT
5. META
6. NVDA
7. SPY
8. NRIX
9. SUNS
10. OIG

Go back to MediWound (MDWD) Tops Q3 EPS by 1c

EMA Provides Regulatory Path for MediWound's (MDWD) NexoBrid

November 18, 2021 7:33 AM EST

MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that the Company has received positive scientific advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the pediatric label extension for NexoBrid. Based on the feedback, the Company anticipates submitting a pediatric label extension request in the first half of 2022.

EMAs CHMP agreed to assess a potential pediatric label extension on NexoBrid for the treatment of thermal burns,... More